Skip to main content

Panic Disorder clinical trials at UCSF
1 in progress, 0 open to eligible people

  • The Role of Orexin in Human Panic Disorder

    Sorry, in progress, not accepting new patients

    The purpose of this study is to provide some information (pilot data) about whether the study drug, suvorexant, (1) affects levels of orexin in people with panic disorder, and (2) is associated with decreased panic symptoms in response to a carbon dioxide (CO2) challenge.

    Fresno, California

Last updated: